D-0104-2021 Class II Terminated
FDA drug recall D-0104-2021 was initiated by Jubilant Cadista Pharmaceuticals, Inc. on November 6, 2020 and is designated Class II. Reason for recall: Failed Tablet/Capsule Specification The recall status is terminated (terminated March 23, 2022). Affected quantity: 4,416 bottles.
Recall Details
- Product Type
- Drugs
- Report Date
- December 2, 2020
- Initiation Date
- November 6, 2020
- Termination Date
- March 23, 2022
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 4,416 bottles
Product Description
clomiPRAMINE Hydrochloride Capsules USP, 50 mg, 30-count bottle, Rx Only, Manufactured by: Jubilant Cadista Pharmaceuticals Inc., Salisbury, MD NDC 59746-711-30
Reason for Recall
Failed Tablet/Capsule Specification
Distribution Pattern
Product was distributed nationwide.
Code Information
Lot# 20P0141, exp. date 02/2022